A novel multi-target small molecule, LCC-09, inhibits stemness and therapy-resistant phenotypes of glioblastoma cells by increasing MIR-34a and deregulating the DRD4/AKT/MTOR signaling axis

研究成果: 雜誌貢獻文章同行評審

2 引文 斯高帕斯(Scopus)

指紋 深入研究「A novel multi-target small molecule, LCC-09, inhibits stemness and therapy-resistant phenotypes of glioblastoma cells by increasing MIR-34a and deregulating the DRD4/AKT/MTOR signaling axis」主題。共同形成了獨特的指紋。

Medicine & Life Sciences